Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction

Urology

Volumn 58, Issue 3, 2001, Pages 441-445

  Kim, Soo Woong ^a   Paick, Jae Seung ^a   Park, Dal Woo ^a   Chae, In Ho ^a   Oh, Byung Hee ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERECTILE DYSFUNCTION; EVALUATION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGE FACTORS; COMORBIDITY; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; HYPERTENSION; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHYSICAL EXAMINATION; PIPERAZINES; PROBABILITY; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 0034859637     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01210-9     Document Type: Article

References (24)

1. Impotence
2. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men
3. Cigarette smoking and other vascular risk factors in vasculogenic impotence
4. Does severity of ischemic heart disease correlate with erectile dysfunction?
5. Sildenafil; an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
6. Oral sildenafil in the treatment of erectile dysfunction
7. Efficacy of sildenafil citrate (Viagra) is not affected by aetiology of erectile dysfunction
8. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
9. Sexual function with advancing age
10. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function; a hemodynamic study
11. A positive pharmacological erection test does not rule out arteriogenic erectile dysfunction
12. Molecular biological characterization of phosphodiesterases 3A and 5 in human corpus cavernosum penis
13. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterase
14. Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue
15. Adverse cardiovascular events associated with the use of Viagra
16. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease
17. Incidence of myocardial infarction and death in 53 clinical trials of Viagra (sildenafil citrate)
18. Acute myocardial infarction associated with sildenafil
19. Sildenafil in the treatment of erectile dysfunction
20. Five-year follow-up of maximal treadmill stress test in asymptomatic men and women
21. Prognostic value of exercise EKG testing in asymptomatic normotensive subjects; a prospective matched study
22. Myocardial ischemia during sexual activity in patients with coronary artery disease
23. Sexual activity after a myocardial infarction